Drug Interaction Report
4 potential interactions and/or warnings found for the following 2 drugs:
- durvalumab
- Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid)
Interactions between your drugs
tetanus toxoid durvalumab
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), durvalumab
If you are currently being treated or are going to begin treatment with durvalumab, you should let your doctor know before receiving tetanus toxoid. Durvalumab can cause potentially serious immune-related side effects and receiving tetanus toxoid during treatment with durvalumab may increase that risk. Your healthcare provider may already be aware of the risks but has determined that this is the best course of treatment for you and is monitoring you closely for any potential complications. You should seek immediate medical attention if you experience severe diarrhea; serious skin reactions such as a widespread rash, peeling skin, or blisters; signs of liver problems like yellowing of your skin or eyes, or pain on the right side of your abdomen; lung issues such as shortness of breath, chest pain, coughing, or extreme fatigue; kidney problems like difficulty urinating, sudden weight gain, or swelling in your feet, ankles, or legs; or thyroid and other endocrine issues such as fatigue, sluggishness, constipation, depression, hoarseness, or unexplained weight gain.
diphtheria toxoid durvalumab
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), durvalumab
If you are currently being treated or are going to begin treatment with durvalumab, you should let your doctor know before receiving diphtheria toxoid. Durvalumab can cause potentially serious immune-related side effects and receiving diphtheria toxoid during treatment with durvalumab may increase that risk. Your healthcare provider may already be aware of the risks but has determined that this is the best course of treatment for you and is monitoring you closely for any potential complications. You should seek immediate medical attention if you experience severe diarrhea; serious skin reactions such as a widespread rash, peeling skin, or blisters; signs of liver problems like yellowing of your skin or eyes, or pain on the right side of your abdomen; lung issues such as shortness of breath, chest pain, coughing, or extreme fatigue; kidney problems like difficulty urinating, sudden weight gain, or swelling in your feet, ankles, or legs; or thyroid and other endocrine issues such as fatigue, sluggishness, constipation, depression, hoarseness, or unexplained weight gain.
pertussis, whole cell durvalumab
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), durvalumab
If you are currently being treated or are going to begin treatment with durvalumab, you should let your doctor know before receiving pertussis, whole cell. Durvalumab can cause potentially serious immune-related side effects and receiving pertussis, whole cell during treatment with durvalumab may increase that risk. Your healthcare provider may already be aware of the risks but has determined that this is the best course of treatment for you and is monitoring you closely for any potential complications. You should seek immediate medical attention if you experience severe diarrhea; serious skin reactions such as a widespread rash, peeling skin, or blisters; signs of liver problems like yellowing of your skin or eyes, or pain on the right side of your abdomen; lung issues such as shortness of breath, chest pain, coughing, or extreme fatigue; kidney problems like difficulty urinating, sudden weight gain, or swelling in your feet, ankles, or legs; or thyroid and other endocrine issues such as fatigue, sluggishness, constipation, depression, hoarseness, or unexplained weight gain.
haemophilus b conjugate (HbOC) vaccine durvalumab
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), durvalumab
If you are currently being treated or are going to begin treatment with durvalumab, you should let your doctor know before receiving haemophilus b conjugate (HbOC) vaccine. Durvalumab can cause potentially serious immune-related side effects and receiving haemophilus b conjugate (HbOC) vaccine during treatment with durvalumab may increase that risk. Your healthcare provider may already be aware of the risks but has determined that this is the best course of treatment for you and is monitoring you closely for any potential complications. You should seek immediate medical attention if you experience severe diarrhea; serious skin reactions such as a widespread rash, peeling skin, or blisters; signs of liver problems like yellowing of your skin or eyes, or pain on the right side of your abdomen; lung issues such as shortness of breath, chest pain, coughing, or extreme fatigue; kidney problems like difficulty urinating, sudden weight gain, or swelling in your feet, ankles, or legs; or thyroid and other endocrine issues such as fatigue, sluggishness, constipation, depression, hoarseness, or unexplained weight gain.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Provera
Provera is used for abnormal uterine bleeding, amenorrhea, birth control, endometrial cancer ...
Depo Provera
Depo-Provera is used as contraception to prevent pregnancy. It is also used to reduce pain cause by ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.